Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Sees Significant Increase in Short Interest

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPFGet Free Report) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 32,300 shares, an increase of 68.2% from the February 29th total of 19,200 shares. Based on an average daily volume of 21,900 shares, the short-interest ratio is presently 1.5 days.

Algernon Pharmaceuticals Trading Up 25.8 %

AGNPF stock opened at $0.08 on Thursday. The stock has a 50-day moving average price of $0.06 and a two-hundred day moving average price of $0.07. Algernon Pharmaceuticals has a 1 year low of $0.04 and a 1 year high of $0.26.

Algernon Pharmaceuticals Company Profile

(Get Free Report)

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.

Featured Articles

Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.